Andre Lieber

Has grant

Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Andre Lieber is a faculty member at the University of Washington in the United States. His research focuses on innovative approaches in gene therapy, particularly concerning hematopoietic stem cells and the development of novel adenovirus vector platforms. Recent publications highlight his work on enhancing complement-dependent cytotoxicity in multiple myeloma and the advancement of gene editing techniques for sickle cell disease and other hematological conditions.

Recent Grants

Grant: Close

In vivo HSC gene therapy for viral infection using decoy receptors

Open Date: 2020-07-01

Close Date: 2021-07-01

Grant: Close

In vivo HSC genome editing

Open Date: 2019-07-01

Close Date: 2021-07-01

Grant: Close

Epithelial junction opener for ovarian cancer therapy

Open Date: 2019-01-01

Close Date:

Grant: Close

Approach for in vivo gene delivery into hematopoietic stem cells for hemophilia A therapy

Open Date: 2018-05-05

Close Date: 2022-04-30

Grant: Close

Combination Therapy of JO-c and PEGylated Liposomal Doxorubicin/Doxil in Ovarian Cancer Patients

Open Date: 2017-07-01

Close Date: 2022-06-30

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Agnieszka Czechowicz

Stanford University

UNITED STATES

View details

Punam Malik

Marjorie Johnson Chair of Gene and Cell Therapy; Professor of Pediatrics

University of Cincinnati

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andre Lieber

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

In vivo HSC transduction in humanized mice mediated by novel capsid-modified HDAd vectors

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2

In vitro and in vivo expansion of CD33/HBG-promoter edited HSPCs with Mylotarg

HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells

Autoantibodies against desmoglein 2 are not pathogenic in pemphigus

Autoanticorpos contra desmogleína 2 não são patogênicos nos pênfigos

In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal g-globin in b-YAC mice

Safe and Effective in Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development

Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice

Binding mechanism elucidation of the acute respiratory disease causing agent adenovirus of serotype 7 to desmoglein-2

Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements

Desmoglein-2 as a prognostic and biomarker in ovarian cancer

Prophylactic in vivo hematopoietic stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models

Collaborators (2)

Agnieszka Czechowicz

Punam Malik

Make your next move.